Transperineal Prostate Access Device

Description

This agreement is for transperineal access devices. Predominantly, the device allows the user to perform transperineal prostate biopsies under local anaesthetic. Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £4,000,000 to £6,000,000 in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. The estimated value over the total Framework Agreement term is £24,000,000. This has the potential to increase depending on patient pathway decisions made.